查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1993855

GMP生物製品市場：依產品類型、應用、服務、生產規模、最終用戶、國家及地區分類－全球產業分析、市場規模、市場佔有率及2025年至2032年預測

GMP Biologics Market, By Product Type, By Application, By Service, By Manufacturing Scale, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 387 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年 GMP 生物製藥市場價值 678.1087 億美元，預計從 2025 年到 2032 年將以 15.98% 的複合年成長率成長。

GMP生物製品是指依照良好生產規範（GMP）大規模生產的生物製藥，GMP獲得國內外監管機構的認可，以確保其品質、安全性和有效性的一致性。生物製品是源自活細胞的聯合療法，包括單株抗體、疫苗、重組蛋白以及先進的細胞和基因療法。由於其結構脆弱且生產流程複雜，從原料採購到最終包裝的每個環節都需要嚴格的法律規範。

從全球管治的角度來看，世界衛生組織（WHO）等組織提供國際認可的藥品生產品質管理規範（GMP）指南，這些指南已被100多個國家採納，旨在協調藥品品質標準。同時，包括美國食品藥物管理局（FDA）和歐洲藥品管理局（EMA）在內的監管機構報告稱，近年來生物製藥和生物類似藥的核准數量穩步成長，這反映出先進治療方法在應對癌症、自體免疫疾病和罕見疾病方面發揮著越來越重要的作用。公共衛生數據顯示，生物製藥目前在主要市場新核准的療法中佔相當大的比例，這凸顯了高品質生物製藥能力的提升以及各國政府對確保全球藥品供應鏈韌性的高度重視。

GMP生物製藥市場－市場動態

對先進生物製藥療法的需求日益成長，以支持長期醫療保健的永續性。

在醫療保健系統中，針對慢性病和複雜疾病的生物製藥療法正日益受到重視，因為人們期望這些療法能夠改善治療效果並減輕長期治療負擔。這種向精準醫療的轉變正在加速對高品質GMP認證生產基礎設施的需求，從而促進市場穩步擴張。隨著癌症和自體免疫疾病等慢性病在全球疾病負擔中所佔比例的不斷上升，世界各國政府都在優先發展生物製藥，以減少住院時間和降低系統性成本。例如，印度政府已在其2026-2027會計年度聯邦預算中撥款12億美元，推出「生物製藥SHAKTI」舉措，該計劃旨在打造一個全球生物製藥和生物類似藥的製造地。同樣，輝瑞和禮來等大型公司正在擴大其符合GMP標準的生產能力以滿足這一需求，預計到2026年，全球生物製藥市場規模將超過5,340億美元。透過確保標靶治療的可擴展生產，GMP生物製藥產業為建立一個具有韌性、以價值為導向的全球醫療保健生態系統提供了必要的基礎設施。

GMP生物製品市場－市場區隔分析：

全球GMP生物製品市場按產品類型、應用、服務、生產規模、最終用戶和地區進行細分。

根據產品類型，全球市場可分為四大類：單株抗體（mAb）、重組蛋白、疫苗、細胞和基因療法。單株抗體被廣泛認為是未來全球生物製藥市場最重要的細分領域。由於單株抗體在治療癌症和自體免疫疾病等重大慢性複雜疾病方面療效顯著，且與許多傳統治療方法相比副作用更少，並能精準靶向疾病通路，因此已佔據全球生物製藥銷售額的最大佔有率。事實上，近年來美國食品藥物管理局（FDA）核准了大量單株抗體療法，其臨床重要性日益凸顯，預計2024年單株抗體核准數量將創下歷史新高。羅氏、艾伯維和輝瑞等領先的生物製藥公司已建構了強大的單株抗體產品組合，並持續擴大符合GMP標準的產能，以滿足全球需求。Herceptin（羅氏）和阿達木單抗（艾伯維）等重磅療法正在推動持續的商業性成功和廣泛應用。

依生產規模，生物製劑市場可分為三類：臨床規模、商業規模及中試規模。預計全球GMP生物製劑市場中，商業規模生產將顯著成長。這是因為商業規模生產能夠在核准的生物製劑療法完成臨床開發階段後，實現大規模、穩定的生產，這對於滿足全球對單株抗體、疫苗和基因療法等治療方法的需求至關重要，並有助於惠及更廣泛的患者群體。像三星生物製劑這樣的領先生產企業，已建成多個產能超過數十萬公升的大規模GMP工廠，並正積極擴大其商業生產基地，以履行與輝瑞等主要製藥合作夥伴的長期供應合約。同時，美國食品藥物管理局（FDA）等監管機構維持嚴格的GMP標準和核准要求，支持從小小規模和臨床生產向全面商業化生物製藥供應的過渡，進一步強化了商業生產基礎設施在確保全球可靠、高品質生物製藥供應方面的核心作用。

GMP生物製藥市場—區域洞察

從地理角度來看，北美預計將繼續保持其作為GMP生物製藥生產和創新中心的重要地位，這得益於其先進的監管基礎設施和強大的公共衛生投資。在美國，食品藥物管理局（FDA）嚴格監管良好生產規範（GMP）的執行情況，以確保高品質生物製藥的生產，並已核准數百種生物製藥用於治療用途。美國擁有龐大的國內需求和工業產能，是全球最大的生物製藥生產基地之一，並在單株抗體、疫苗和重組蛋白領域擁有強大的開發平臺。加拿大也為該地區的優勢做出了貢獻，生物製藥在其國內藥品支出中佔有相當大的比例，這表明生物治療藥物正在不斷融入其醫療保健體系。

從行業角度來看，領先的製藥和生物技術公司正在北美擴大其生物製藥生產能力，以服務國內和出口市場。安進和輝瑞等創新美國公司經營符合GMP標準的大規模生產設施，並持續投資下一代生物製藥生產技術。這些公司正與聯邦機構密切合作，在遵守不斷發展的品質標準的同時，提高生產效率。在加拿大，國家監管指南鼓勵遵守國際GMP標準，從而促進了跨境製藥活動。整體而言，北美的監管保障、醫療保健需求和企業投資支撐著該地區在全球GMP生物製藥市場中的重要地位。

中國GMP生物製藥市場－各國概況

在積極的政府政策和國內產業能力提升的推動下，中國在生物製藥製造領域扮演日益重要的角色。 2024年底，國家藥品監督管理局推出了分階段生物製藥生產試驗計畫。該專案允許生產企業專注於生物製藥生產的不同階段，從而提高生產效率並確保符合GMP標準。藥明生物和中國醫藥集團等主要企業正為中國生物製藥生產做出重大貢獻，其產品涵蓋疫苗、抗體醫藥品和複雜治療性蛋白質等。這些發展體現了中國致力於強化製造業生態系統、提升監管完整性和支持創新，以滿足國內醫療需求並掌握不斷擴大的出口機會的戰略重點。

目錄

第1章：GMP生物製品市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：GMP生物製品市場的主要趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：GMP生物製品產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章：GMP生物製品市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：GMP生物製品市場趨勢

  • GMP生物製品市佔率分析，2024年
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 GMP生物製品市場：依產品類型分類

  • 概述
    • 基於細分市場的市場佔有率分析：按產品類型
    • 單株抗體（mAbs）
    • 重組蛋白
    • 疫苗
    • 細胞和基因治療

第8章 GMP生物製品市場：依應用分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 腫瘤學
    • 免疫學
    • 感染疾病
    • 罕見疾病
    • 心血管疾病

第9章 GMP生物製品市場：依服務分類

  • 概述
    • 基於細分市場的市佔率分析：按服務
    • 製程開發
    • 分析測試服務
    • 灌裝和包裝服務
    • 上游工程
    • 下游加工

第10章 GMP生物製品市場：依生產規模分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 臨床量表
    • 商業規模
    • 中試規模

第11章 GMP生物製品市場：依最終用戶分類

  • 概述
    • 生物製藥公司
    • 合約研發生產組織（CDMO）
    • 研究機構
    • 臨床研究機構（CRO）

第12章 GMP生物製品市場：按地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他中東和非洲國家

第13章：主要供應商分析：GMP生物製品產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • Samsung Biologics
    • WuXi Biologics
    • Amgen Inc.
    • Pfizer Inc.
    • Roche Holding AG
    • Novartis AG
    • Merck & Co.
    • Bristol Myers Squibb
    • Sanofi
    • Lonza Group
    • Catalent Inc.
    • Thermo Fisher Scientific
    • Cobra Biologics
    • AstraZeneca plc
    • Charles River Laboratories International, Inc.
    • Rentschler Biopharma SE
    • Others

第14章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV6158

GMP Biologics Market size was valued at US$ 67,810.87 Million in 2024, expanding at a CAGR of 15.98% from 2025 to 2032.

GMP Biologics refers to biological medicines that are mass-produced in compliance with Good Manufacturing Practice (GMP) standards recognized by national and international regulatory authorities to ensure consistent quality, safety, and effectiveness. Biologics are compound therapies derived from living cells and include monoclonal antibodies, vaccines, recombinant proteins, and advanced cell and gene therapies. Due to their structural sensitivity and sophisticated production processes, strict regulatory oversight is required at every stage from raw material sourcing to final packaging.

From a global governance view, institutions such as the World Health Organization provide internationally recognized GMP guidelines adopted by more than 100 countries to harmonize pharmaceutical quality standards. In parallel, regulatory authorities, including the U.S. Food and Drug Administration and the European Medicines Agency (EMA), have reported a consistent rise in biologics and biosimilar approvals over recent years, reflecting the growing role of advanced therapies in addressing cancer, autoimmune disorders, and rare diseases. Public health data further specify that biologic products now represent a significant share of newly approved therapeutic agents in major markets, underscoring strong governmental emphasis on expanding high-quality biomanufacturing capacity and ensuring resilient pharmaceutical supply chains worldwide.

GMP Biologics Market- Market Dynamics

Rising demand for advanced biologic therapies to support long-term healthcare sustainability

Healthcare systems are increasingly prioritizing targeted biologic treatments for chronic and complex diseases due to their potential to improve outcomes and reduce long-term treatment burden. This shift toward precision medicine is accelerating the need for high-quality GMP-certified production infrastructure, contributing to steady market expansion. As chronic conditions like cancer and autoimmune disorders increasingly dominate the global disease burden, governments are prioritizing biologics to reduce long-term hospitalizations and systemic costs. For instance, the Government of India, in its Union Budget 2026-27, launched the "Biopharma SHAKTI" initiative with an outlay of $1.2 billion to establish a global manufacturing hub for biologics and biosimilars. Similarly, corporate leaders like Pfizer and Eli Lilly are scaling GMP-compliant production to meet this need, with the global biologics market projected to exceed $534 billion by 2026. By ensuring the scalable production of targeted therapies, the GMP biologics sector provides the essential infrastructure for a resilient, value-based global healthcare ecosystem.

GMP Biologics Market- Segmentation Analysis:

The Global GMP Biologics Market is segmented on the basis of Product Type, Application, Service, Manufacturing Scale, End User, and Region.

On the basis of product type global market is divided into four categories: Monoclonal Antibodies (mAbs), Recombinant Proteins, Vaccines, and Cell & Gene Therapies. Monoclonal Antibodies are widely acknowledged as the segment set to play the most pivotal role in the global biologics market in the near term. mAbs already account for the largest share of biologics revenue globally due to their proven effectiveness in treating major chronic and complex diseases such as cancer and autoimmune disorders, and their ability to target disease pathways with precision and fewer side effects than many traditional therapies. In fact, the U.S. Food and Drug Administration (FDA) approved a notably high number of monoclonal antibody therapies in recent years, including a record number of mAb approvals in 2024, reinforcing their clinical importance. Major biopharmaceutical players such as Roche, AbbVie, and Pfizer have built robust monoclonal antibody portfolios and continue to expand GMP-compliant production capacity to meet global demand, with blockbuster therapies like Herceptin (Roche) and Humira (AbbVie) driving sustained commercial performance and uptake.

The market is divided into three categories based on manufacturing scale: Clinical Scale, Commercial Scale, and Pilot Scale. Commercial-scale manufacturing is forecasted to register meaningful growth in the GMP biologics market at a global level because it enables the large volume, consistent production of approved biologic therapies once they clear clinical development, which is essential to meet worldwide demand for treatments such as monoclonal antibodies, vaccines, and gene-based therapies and to support broad patient access. Leading manufacturing specialists like Samsung Biologics, which has built multiple large capacity GMP plants exceeding hundreds of thousands of liters, are actively expanding their commercial production footprint to serve long term supply contracts with major pharmaceutical partners such as Pfizer and others. At the same time, regulators like the U.S. Food and Drug Administration (FDA) maintain stringent GMP expectations and approvals that underpin the transition from small-scale and clinical production to full-scale commercial biologics supply, reinforcing the central role of commercial manufacturing infrastructure in ensuring reliable, high-quality biologic availability worldwide.

GMP Biologics Market- Geographical Insights

From the geographical point of view shows that North America is expected to remains a influential hub for GMP biologics manufacturing and innovation, supported by advanced regulatory infrastructure and strong public health investment. In the United States, the U.S. Food and Drug Administration oversees stringent good manufacturing practice (GMP) compliance, ensuring high-quality biologics production, and has approved hundreds of biologic products for therapeutic use. The U.S. benefits from one of the largest concentrations of biologics manufacturing facilities and a robust pipeline of monoclonal antibodies, vaccines, and recombinant proteins, reflecting broad domestic demand and industry capability. Canada also contributes to regional strength, with biologics accounting for a significant share of national pharmaceutical expenditure, indicating sustained integration of biotherapeutic products within healthcare systems.

From an industry perception, leading pharmaceutical and biotech companies are expanding their biologics manufacturing capacity in North America to serve both domestic and export markets. U.S.-based innovators like Amgen and Pfizer operate large GMP-compliant facilities and continue to invest in next-generation biologic production technologies. These firms work closely with federal agencies to adhere to evolving quality standards while advancing production efficiency. In Canada, national regulatory guidance encourages alignment with international GMP standards, supporting cross-border pharmaceutical activities. Collectively, North America's regulatory assurance, healthcare demand, and corporate investment underpin its influential role in the global GMP biologics landscape.

China GMP Biologics Market- Country Insights

China has become an increasingly important player in biologics manufacturing, driven by proactive government policies and growing domestic industry capabilities. The National Medical Products Administration introduced a pilot program for segmented production of biological products in late 2024, enabling facilities to specialize in different stages of biologics manufacturing to improve efficiency and support compliance with GMP standards. Major Chinese firms such as WuXi Biologics and state-owned China National Pharmaceutical Group Corporation contribute significantly to the country's biologics output, including vaccines, antibody drugs, and complex therapeutic proteins. These developments reflect China's strategic focus on strengthening its manufacturing ecosystem, enhancing regulatory alignment, and supporting innovation to meet both domestic healthcare needs and expanding export opportunities.

GMP Biologics Market- Competitive Landscape:

Driven by the growing demand for advanced therapeutics and biologic treatments, the global GMP biologics market comprises both multinational pharmaceutical companies and regional manufacturers, making it a highly competitive sector. Companies distribute biologics through contract manufacturing, direct partnerships with healthcare providers, and specialized biopharmaceutical channels. Market participants compete on factors such as production quality, compliance with GMP standards, technological capabilities, cost efficiency, and regulatory alignment. Key strategies to strengthen market presence include expanding production capabilities, enhancing research and development initiatives, forming strategic partnerships, and pursuing targeted acquisitions. For example, WuXi Biologics and Samsung Biologics continue to strengthen global reach through advanced manufacturing facilities and strategic partnerships.

Recent Developments:

In December 2025, Samsung Biologics announced it would acquire its first U.S. drug production facility from GlaxoSmithKline for about $280 million, enabling expanded biologics production capacity in the United States and strengthening its long term manufacturing footprint.

In April 2025, WuXi Biologics completed its first commercial Process Performance Qualification (PPQ) campaign at a new 15,000L production line at its Hangzhou site. This milestone marks the successful scaling of one of Asia's largest single-use bioreactor systems, enhancing the company's commercial manufacturing capabilities.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GMP BIOLOGICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Samsung Biologics
  • WuXi Biologics
  • Amgen Inc.
  • Pfizer Inc.
  • Roche Holding AG
  • Novartis AG
  • Merck & Co.
  • Bristol Myers Squibb
  • Sanofi
  • Lonza Group
  • Catalent Inc.
  • Thermo Fisher Scientific
  • Cobra Biologics
  • AstraZeneca plc
  • Charles River Laboratories International, Inc.
  • Rentschler Biopharma SE
  • Others

GLOBAL GMP BIOLOGICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Monoclonal Antibodies (mAbs)
  • Recombinant Proteins
  • Vaccines
  • Cell & Gene Therapies

GLOBAL GMP BIOLOGICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Immunology
  • Infectious Diseases
  • Rare Diseases
  • Cardiovascular Diseases

GLOBAL GMP BIOLOGICS MARKET, BY SERVICE- MARKET ANALYSIS, 2019 - 2032

  • Process Development
  • Analytical Testing Service
  • Fill-Finish Service
  • Upstream Manufacturing
  • Downstream Processing

GLOBAL GMP BIOLOGICS MARKET, BY MANUFACTURING SCALE- MARKET ANALYSIS, 2019 - 2032

  • Clinical Scale
  • Commercial Scale
  • Pilot Scale

GLOBAL GMP BIOLOGICS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Biopharmaceutical Companies
  • Contract Development & Manufacturing Organizations (CDMOs)
  • Research Institutes
  • Clinical Research Organizations (CROs)

GLOBAL GMP BIOLOGICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. GMP Biologics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. GMP Biologics Market Snippet by Product Type
    • 2.1.2. GMP Biologics Market Snippet by Application
    • 2.1.3. GMP Biologics Market Snippet by Service
    • 2.1.4. GMP Biologics Market Snippet by Manufacturing Scale
    • 2.1.5. GMP Biologics Market Snippet by End User
    • 2.1.6. GMP Biologics Market Snippet by Country
    • 2.1.7. GMP Biologics Market Snippet by Region
  • 2.2. Competitive Insights

3. GMP Biologics Key Market Trends

  • 3.1. GMP Biologics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. GMP Biologics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. GMP Biologics Market Opportunities
  • 3.4. GMP Biologics Market Future Trends

4. GMP Biologics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. GMP Biologics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. GMP Biologics Market Landscape

  • 6.1. GMP Biologics Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. GMP Biologics Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Monoclonal Antibodies (mAbs)
    • 7.1.3. Recombinant Proteins
    • 7.1.4. Vaccines
    • 7.1.5. Cell & Gene Therapies

8. GMP Biologics Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Oncology
    • 8.1.3. Immunology
    • 8.1.4. Infectious Diseases
    • 8.1.5. Rare Diseases
    • 8.1.6. Cardiovascular Diseases

9. GMP Biologics Market - By Service

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Service, 2024 & 2032 (%)
    • 9.1.2. Process Development
    • 9.1.3. Analytical Testing Services
    • 9.1.4. Fill-Finish Services
    • 9.1.5. Upstream Manufacturing
    • 9.1.6. Downstream Processing

10. GMP Biologics Market - By Manufacturing Scale

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 10.1.2. Clinical Scale
    • 10.1.3. Commercial Scale
    • 10.1.4. Pilot Scale

11. GMP Biologics Market - By End User

  • 11.1. Overview
    • 11.1.1. Biopharmaceutical Companies
    • 11.1.2. Contract Development & Manufacturing Organizations (CDMOs)
    • 11.1.3. Research Institutes
    • 11.1.4. Clinical Research Organizations (CROs)

12. GMP Biologics Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. GMP Biologics Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. GMP Biologics Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.3.18. Rest of Europe
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.3.18.5. Rest of the Europe Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.3.18.6. Rest of the Europe Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. GMP Biologics Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. GMP Biologics Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. GMP Biologics Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Manufacturing Scale, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- GMP Biologics Industry

  • 13.1. Competitive Benchmarking
    • 13.1.1. Competitive Dashboard
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Samsung Biologics
    • 13.2.2. WuXi Biologics
    • 13.2.3. Amgen Inc.
    • 13.2.4. Pfizer Inc.
    • 13.2.5. Roche Holding AG
    • 13.2.6. Novartis AG
    • 13.2.7. Merck & Co.
    • 13.2.8. Bristol Myers Squibb
    • 13.2.9. Sanofi
    • 13.2.10. Lonza Group
    • 13.2.11. Catalent Inc.
    • 13.2.12. Thermo Fisher Scientific
    • 13.2.13. Cobra Biologics
    • 13.2.14. AstraZeneca plc
    • 13.2.15. Charles River Laboratories International, Inc.
    • 13.2.16. Rentschler Biopharma SE
    • 13.2.17. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us